11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

28 trials found

diseases per page:

Showing 1 to 10 of 28 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-002460-46-AT (EUCTR)	16/09/2022	23/05/2022	Evaluating Long-term Safety of Efgartigimod Administered Intravenously in Children With Generalized ...	A Long-term, Single-Arm, Open-label, Multicenter, Follow-on Trial of ARGX113-2006 to Evaluate Safety ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Belgium;Spain;Poland;Austria;Georgia;Germany;Netherlands;United Kingdom; ...
2	EUCTR2020-005841-18-NL (EUCTR)	15/04/2022	19/07/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intraveno ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Germany;Netherlands;United Kingdom; ...
3	EUCTR2021-002460-46-ES (EUCTR)	04/04/2022	02/02/2022	Evaluating Long-term Safety of Efgartigimod Administered Intravenously in Children With Generalized ...	A Long-term, Single-Arm, Open-label, Multicenter, Follow-on Trial of ARGX113-2006 to Evaluate Safety ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	United States;France;Canada;Poland;Belgium;Spain;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
4	EUCTR2020-005841-18-DE (EUCTR)	09/02/2022	30/08/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intraveno ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
5	EUCTR2021-002504-12-PL (EUCTR)	01/12/2021	24/09/2021	An open-label study to investigate the clinical efficacy of different dosing regimens of efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis (gMG) MedDRA version: 21.1;Level: PT;Classification code 10028417;Term ...	Product Code: ARGX-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 3	France;United States;Canada;Spain;Belgium;Poland;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
6	EUCTR2020-005841-18-IT (EUCTR)	29/11/2021	25/08/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intraveno ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: [argx-113] INN or Proposed INN: EFGARTIGIMOD ALFA	ARGENX BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
7	EUCTR2021-002504-12-ES (EUCTR)	26/11/2021	02/12/2021	An open-label study to investigate the clinical efficacy of different dosing regimens of efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis (gMG) MedDRA version: 21.1;Level: PT;Classification code 10028417;Term ...	Product Code: ARGX-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	72	Phase 3	France;United States;Canada;Poland;Belgium;Spain;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
8	EUCTR2020-005841-18-ES (EUCTR)	05/10/2021	06/10/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intraveno ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Poland;Belgium;Spain;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
9	EUCTR2020-005841-18-BE (EUCTR)	29/09/2021	21/06/2021	Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intraveno ...	Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity o ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: efgartigimod Product Code: argx-113 INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2;Phase 3	France;United States;Canada;Spain;Poland;Belgium;Austria;Georgia;Netherlands;Germany;United Kingdom; ...
10	EUCTR2020-004086-38-DE (EUCTR)	06/08/2021	12/02/2021	Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously ...	A Long-Term, Single-Arm, Open-label, Multicenter Phase 3 Study to Evaluate the Safety and Tolerabili ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Efgartigimod PH20 SC INN or Proposed INN: EFGARTIGIMOD ALFA	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	201	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;Hungary;Canada;Poland;Bel ...

First Previous1 2 3Next Last